搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
生物通
28 天
Vertex 非阿片镇痛药获批,开启 NaV1.8 靶点疼痛治疗新时代
最近获批的 Journavx 对 NaV1.1 - 1.7 和 NaV1.9 的亲和力达到亚纳摩尔级别,且选择性超过 31000 倍。 在该药物的 3 期临床试验中,2000 多名接受拇囊炎切除手术或腹部整容手术的患者,分别每 12 小时服用一次 Journavx、每 6 小时服用标准治疗药物氢可酮(一种半合成阿片 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
'Get Together' singer dies
To return as host in 2026
DC drops Jan. 6 lawsuit
Trump revokes protection
JFK files to be released
Acquires AI video startup
Postpones book tour
PepsiCo to buy Poppi
Ordered to pay $54K+
Texas midwife arrested
Morgan gets sick at MSG
Expanding free tuition
HK property tycoon dies
Bryan Bedford to lead FAA
Worker stole $1.6 million
Lunar lander goes silent
Peru declares emergency
Producer files for bankruptcy
Tapped as top bank cop
Ex-Texas pastor surrenders
Visits White House
iHeartRadio Music Awards
H7N9 bird flu outbreak
Judge cancels hearing
ISR conducts strikes in Gaza
Pennsylvania bus crash
Judge demands answers
DOGE gains access to USIP?
First direct images of CO2
US retail sales rebound
Stuck astronauts depart ISS
Halts care for trans veterans
反馈